-
1
-
-
34548438462
-
Therapeutic options for hormone-refractory prostate cancer in 2007
-
B. A. Hadaschik and M. E. Gleave, Therapeutic options for hormone-refractory prostate cancer in 2007. Urol. Oncol. 25, 413 (2007).
-
(2007)
Urol. Oncol.
, vol.25
, pp. 413
-
-
Hadaschik, B.A.1
Gleave, M.E.2
-
2
-
-
77953419972
-
A small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro
-
Y. Dai and D. W. Siemann, A small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro. Mol. Cancer Ther. 9, 1554 (2010).
-
(2010)
Mol. Cancer Ther.
, vol.9
, pp. 1554
-
-
Dai, Y.1
Siemann, D.W.2
-
3
-
-
7144248725
-
Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptothecaaccuminata
-
M. E. Wall, M. C. Wani, C. E. Cook, K. H. Palmer, A. T. McPhail, and G. A. Sim, Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptothecaaccuminata. J. Am. Chem. 88, 3888 (1966).
-
(1966)
J. Am. Chem.
, vol.88
, pp. 3888
-
-
Wall, M.E.1
Wani, M.C.2
Cook, C.E.3
Palmer, K.H.4
McPhail, A.T.5
Sim, G.A.6
-
4
-
-
0030055094
-
Current perspectives on camptothecin in cancer treatment
-
J. Dancey and E. A. Eisenhauer, Current perspectives on camptothecin in cancer treatment. Br. J. Cancer 74, 327 (1996).
-
(1996)
Br. J. Cancer
, vol.74
, pp. 327
-
-
Dancey, J.1
Eisenhauer, E.A.2
-
5
-
-
84960175480
-
-
edited by CRC Press, Boca Raton FL, USA
-
M. Potmesil and H. M. Pinedo, Camptothecins: New Anticancer Agents, edited by CRC Press, Boca Raton FL, USA (2005), pp. 5-21.
-
(2005)
Camptothecins: New Anticancer Agents
, pp. 5-21
-
-
Potmesil, M.1
Pinedo, H.M.2
-
7
-
-
0027096415
-
A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues
-
J. Fassberg and V. J. Stella, A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J. Pharm. 81, 676 (1992).
-
(1992)
J. Pharm.
, vol.81
, pp. 676
-
-
Fassberg, J.1
Stella, V.J.2
-
8
-
-
0032473430
-
Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy
-
I. Chourpa, J. M. Millot, G. D. Sockalingum, J. F. Riou, and M. Manfait, Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy. Biochim. Biophys. Acta 1379, 353 (1998).
-
(1998)
Biochim. Biophys. Acta
, vol.1379
, pp. 353
-
-
Chourpa, I.1
Millot, J.M.2
Sockalingum, G.D.3
Riou, J.F.4
Manfait, M.5
-
9
-
-
0027276081
-
Lipid bilayer partitioning and stability of camptothecin drugs
-
T. G. Burke, A. K. Mishra, M. C. Wani, and M. E. Wall, Lipid bilayer partitioning and stability of camptothecin drugs. Biochemistry 32, 5352 (1993).
-
(1993)
Biochemistry
, vol.32
, pp. 5352
-
-
Burke, T.G.1
Mishra, A.K.2
Wani, M.C.3
Wall, M.E.4
-
10
-
-
0029593371
-
Liposomal encapsulation increases the activity of the topoisomerase I inhibitor topotecan
-
D. Subramanian and M. T. Muller, Liposomal encapsulation increases the activity of the topoisomerase I inhibitor topotecan. Oncol. Res. 7, 461 (1995).
-
(1995)
Oncol. Res.
, vol.7
, pp. 461
-
-
Subramanian, D.1
Muller, M.T.2
-
11
-
-
0031441796
-
Photodegradation of irinotecan (CPT-11) in aqueous solutions: Identification of fluorescent products and influence of solution composition
-
H. M. Dodds, D. J. Craik, and L. P. Rivory, Photodegradation of irinotecan (CPT-11) in aqueous solutions: Identification of fluorescent products and influence of solution composition. J. Pharm. Sci. 86, 1410 (1997).
-
(1997)
J. Pharm. Sci.
, vol.86
, pp. 1410
-
-
Dodds, H.M.1
Craik, D.J.2
Rivory, L.P.3
-
12
-
-
33749249529
-
Irinotecan in the treatment of colorectal cancer
-
C. Fuchs, E. P. Mitchell, and P. M. Hoff, Irinotecan in the treatment of colorectal cancer. Cancer Treat. Rev. 32, 491 (2006).
-
(2006)
Cancer Treat. Rev.
, vol.32
, pp. 491
-
-
Fuchs, C.1
Mitchell, E.P.2
Hoff, P.M.3
-
13
-
-
84861886858
-
Comparative and cost-effectiveness of oxaliplatinbased or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients
-
C. D. Mullins, F. Y. Hsiao, E. Onukwugha, N. B. Pandya, and N. Hanna, Comparative and cost-effectiveness of oxaliplatinbased or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients. Cancer 118, 3173 (2012).
-
(2012)
Cancer
, vol.118
, pp. 3173
-
-
Mullins, C.D.1
Hsiao, F.Y.2
Onukwugha, E.3
Pandya, N.B.4
Hanna, N.5
-
14
-
-
0036803284
-
Camptothecin delivery methods
-
A. Hatefi and B. Amsden, Camptothecin delivery methods. Pharm. Res. 19, 1389 (2002).
-
(2002)
Pharm. Res.
, vol.19
, pp. 1389
-
-
Hatefi, A.1
Amsden, B.2
-
15
-
-
75449094412
-
Cyclodextrinbased nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity
-
S. Swaminathan, L. Pastero, L. Serpe, F. Trotta, P. Vavia, D. Aquilano, M. Trotta, G. Zara, and R. Cavalli, Cyclodextrinbased nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity. Eur. J. Pharm. Biopharm. 74, 193 (2010).
-
(2010)
Eur. J. Pharm. Biopharm.
, vol.74
, pp. 193
-
-
Swaminathan, S.1
Pastero, L.2
Serpe, L.3
Trotta, F.4
Vavia, P.5
Aquilano, D.6
Trotta, M.7
Zara, G.8
Cavalli, R.9
-
16
-
-
84862689147
-
Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer
-
S. Gaur, L. Chen, T. Yen, Y. Wang, B. Zhou, M. Davis, and Y. Yen, Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer. Nanomedicine 8, 721 (2012).
-
(2012)
Nanomedicine
, vol.8
, pp. 721
-
-
Gaur, S.1
Chen, L.2
Yen, T.3
Wang, Y.4
Zhou, B.5
Davis, M.6
Yen, Y.7
-
17
-
-
84876570501
-
Lab-on-achip for anticancer drug screening using quantum dots probe based apoptosis assay
-
L. Zhao, J. T. Caot, Z. Q. Wu, J. X. Li, and J. J. Zhu, Lab-on-achip for anticancer drug screening using quantum dots probe based apoptosis assay. J. Biomed. Nanotechnol. 9, 348 (2013).
-
(2013)
J. Biomed. Nanotechnol.
, vol.9
, pp. 348
-
-
Zhao, L.1
Caot, J.T.2
Wu, Z.Q.3
Li, J.X.4
Zhu, J.J.5
-
18
-
-
84918583952
-
Nanomicelle based peroral delivery system for enhanced absorption and sustained release of 10-Hydrocamptothecin
-
Y. Tian, C. Shi, X. Zhang, Y. Sun, J. Wang, Y. Zhang, J. Yang, L. Wang, L. Wang, and M. Shirui, Nanomicelle based peroral delivery system for enhanced absorption and sustained release of 10-Hydrocamptothecin. J. Biomed. Nanotechnol. 11, 262 (2015).
-
(2015)
J. Biomed. Nanotechnol.
, vol.11
, pp. 262
-
-
Tian, Y.1
Shi, C.2
Zhang, X.3
Sun, Y.4
Wang, J.5
Zhang, Y.6
Yang, J.7
Wang, L.8
Wang, L.9
Shirui, M.10
-
19
-
-
84958908977
-
A review on anticancer potential of bioactive heterocyclequinoline
-
O. Afzal, S. Kumar, M. R. Haider, M. R. Ali, R. Kumar, M. Jaggi, and S. Bawa, A review on anticancer potential of bioactive heterocyclequinoline. Eur. J. Med. Chem. 14, 651 (2014).
-
(2014)
Eur. J. Med. Chem.
, vol.14
, pp. 651
-
-
Afzal, O.1
Kumar, S.2
Haider, M.R.3
Ali, M.R.4
Kumar, R.5
Jaggi, M.6
Bawa, S.7
-
20
-
-
84883508947
-
Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38
-
V. Bala, S. Rao, B. J. Boyd, and C. A. Prestidge, Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38. J. Control. Release 172, 48 (2013).
-
(2013)
J. Control. Release
, vol.172
, pp. 48
-
-
Bala, V.1
Rao, S.2
Boyd, B.J.3
Prestidge, C.A.4
-
21
-
-
84881631402
-
Nanocarriers for anticancer drugs-new trends in nanomedicine
-
J. Drbohlavova, J. Chomoucka, V. Adam, M. Ryvolova, T. Eckschlager, J. Hubalek, and R. Kizek, Nanocarriers for anticancer drugs-new trends in nanomedicine. Curr Drug Metab. 14, 547 (2013).
-
(2013)
Curr Drug Metab.
, vol.14
, pp. 547
-
-
Drbohlavova, J.1
Chomoucka, J.2
Adam, V.3
Ryvolova, M.4
Eckschlager, T.5
Hubalek, J.6
Kizek, R.7
-
22
-
-
84898473475
-
Uptake mechanism and endosomal fate of drug-phospholipid lipid nanoparticles in subcutaneous and in situ hepatoma
-
Q. Wang, P. Liu, T. Gong, X. Sun, Y. Duan, and Z. Zhang, Uptake mechanism and endosomal fate of drug-phospholipid lipid nanoparticles in subcutaneous and in situ hepatoma. J. Biomed. Nanotechnol. 10, 993 (2014).
-
(2014)
J. Biomed. Nanotechnol.
, vol.10
, pp. 993
-
-
Wang, Q.1
Liu, P.2
Gong, T.3
Sun, X.4
Duan, Y.5
Zhang, Z.6
-
24
-
-
0346461917
-
Introduction and general overview of cyclodextrin chemistry
-
J. Szejtl, Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98, 743 (1998).
-
(1998)
Chem. Rev.
, vol.98
, pp. 743
-
-
Szejtl, J.1
-
25
-
-
0037368504
-
Biochemical and genetic analyses of a novel gamma-cyclodextringlucanotransferase from an alkalophilic Bacillus clarkia
-
M. Takada, Y. Nakagawa, and M. Yamamoto, Biochemical and genetic analyses of a novel gamma-cyclodextringlucanotransferase from an alkalophilic Bacillus clarkia. J. Biochim. 133, 317 (2003).
-
(2003)
J. Biochim.
, vol.133
, pp. 317
-
-
Takada, M.1
Nakagawa, Y.2
Yamamoto, M.3
-
26
-
-
84891602371
-
Cyclodextrin containing biodegradable particles: From preparation to drug delivery applications
-
N. Zafir, H. Fessi, and A. Elaissari, Cyclodextrin containing biodegradable particles: From preparation to drug delivery applications. International Journal of Pharmaceutics 461, 351 (2013).
-
(2013)
International Journal of Pharmaceutics
, vol.461
, pp. 351
-
-
Zafir, N.1
Fessi, H.2
Elaissari, A.3
-
27
-
-
33644556465
-
Molecular cloning and characterization of a novel gamma-CGTase from alkalophilic Bacillus sp
-
K. Hirano, T. Ishihara, S. Ogasawara, H. Maeda, K. Abe, T. Nakajima, and Y. Yamagata, Molecular cloning and characterization of a novel gamma-CGTase from alkalophilic Bacillus sp. Appl. Microbiol. Biotechnol. 70, 193 (2006).
-
(2006)
Appl. Microbiol. Biotechnol.
, vol.70
, pp. 193
-
-
Hirano, K.1
Ishihara, T.2
Ogasawara, S.3
Maeda, H.4
Abe, K.5
Nakajima, T.6
Yamagata, Y.7
-
28
-
-
51649088096
-
GammaCD/HPgammaCD: Synergistic solubilization
-
P. Jansook and T. Loftsson, GammaCD/HPgammaCD: Synergistic solubilization. Int. J. Pharm. 363, 217 (2008).
-
(2008)
Int. J. Pharm.
, vol.363
, pp. 217
-
-
Jansook, P.1
Loftsson, T.2
-
31
-
-
0032918773
-
Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrins
-
R. Cavalli, E. Peira, O. Caputo, and M. R. Gasco, Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrins. Int. J. Pharm. 182, 59 (1999).
-
(1999)
Int. J. Pharm.
, vol.182
, pp. 59
-
-
Cavalli, R.1
Peira, E.2
Caputo, O.3
Gasco, M.R.4
-
32
-
-
84866489239
-
Nanosponge-encapsulated camptothecinexerts anti-tumor activity in human prostate cancercells
-
R. Minelli, R. Cavalli, L. Ellis, P. Pettazzoni, F. Trotta, E. Ciamporcero, G. Barrera, R. Fantozzi, C. Dianzani, and R. Pili, Nanosponge-encapsulated camptothecinexerts anti-tumor activity in human prostate cancercells. Eur. J. Pharm. Sci. 47, 686 (2012).
-
(2012)
Eur. J. Pharm. Sci.
, vol.47
, pp. 686
-
-
Minelli, R.1
Cavalli, R.2
Ellis, L.3
Pettazzoni, P.4
Trotta, F.5
Ciamporcero, E.6
Barrera, G.7
Fantozzi, R.8
Dianzani, C.9
Pili, R.10
-
33
-
-
84859883485
-
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells
-
R. Minelli, L. Serpe, P. Pettazzoni, V. Minero, G. Barrera, C. Gigliotti, R. Mesturini, A. Rosa, P. Gasco, N. Vivenza, E. Muntoni, R. Fantozzi, U. Dianzani, G. Zara, and C. Dianzani, Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells. Br. J. Pharmacol. 166, 587 (2012).
-
(2012)
Br. J. Pharmacol.
, vol.166
, pp. 587
-
-
Minelli, R.1
Serpe, L.2
Pettazzoni, P.3
Minero, V.4
Barrera, G.5
Gigliotti, C.6
Mesturini, R.7
Rosa, A.8
Gasco, P.9
Vivenza, N.10
Muntoni, E.11
Fantozzi, R.12
Dianzani, U.13
Zara, G.14
Dianzani, C.15
-
34
-
-
77958137498
-
B7h triggering inhibit sumbilicalvascular endothelial cell adhesiveness to tumor cell lines and polymorpho nuclear cells
-
C. Dianzani, R. Minelli, R. Mesturini, A. Chiocchetti, G. Barrera, S. Boscolo, C. Sarasso, C. L. Gigliotti, D. Sblattero, J. Yagi, J. M. Rojo, R. Fantozzi, and U. Dianzani, B7h triggering inhibit sumbilicalvascular endothelial cell adhesiveness to tumor cell lines and polymorpho nuclear cells. J. Immunol. 185, 3970 (2010).
-
(2010)
J. Immunol.
, vol.185
, pp. 3970
-
-
Dianzani, C.1
Minelli, R.2
Mesturini, R.3
Chiocchetti, A.4
Barrera, G.5
Boscolo, S.6
Sarasso, C.7
Gigliotti, C.L.8
Sblattero, D.9
Yagi, J.10
Rojo, J.M.11
Fantozzi, R.12
Dianzani, U.13
-
35
-
-
23144432272
-
Discovery and preclinical evaluation of a novel class of small-molecule compound in hormone-dependent and -independent cancer cell lines
-
C. Plasencia, R. Dayam, Q. Wang, J. Pinski, T. R. Burke, Jr., D. I. Quinn, and N. Nemati, Discovery and preclinical evaluation of a novel class of small-molecule compound in hormone-dependent and -independent cancer cell lines. Mol. Cancer Ther 4, 1105 (2005).
-
(2005)
Mol. Cancer Ther
, vol.4
, pp. 1105
-
-
Plasencia, C.1
Dayam, R.2
Wang, Q.3
Pinski, J.4
Burke, T.R.5
Quinn, D.I.6
Nemati, N.7
-
36
-
-
84868319447
-
A complex of β6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6
-
S. Marchiò, M. Soster, S. Cardaci, A. Muratore, A. Bartolini, V. Barone, D. Ribero, M. Monti, P. Bovino, J. Sun, R. Giavazzi, S. Asioli, P. Cassoni, L. Capussotti, P. Pucci, A. Bugatti, M. Rusnati, R. Pasqualini, W. Arap, and F. Bussolino, A complex of β6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. EMBO Mol. Med. 4, 1156 (2012).
-
(2012)
EMBO Mol. Med.
, vol.4
, pp. 1156
-
-
Marchiò, S.1
Soster, M.2
Cardaci, S.3
Muratore, A.4
Bartolini, A.5
Barone, V.6
Ribero, D.7
Monti, M.8
Bovino, P.9
Sun, J.10
Giavazzi, R.11
Asioli, S.12
Cassoni, P.13
Capussotti, L.14
Pucci, P.15
Bugatti, A.16
Rusnati, M.17
Pasqualini, R.18
Arap, W.19
Bussolino, F.20
more..
-
37
-
-
80053241188
-
Mechanism of cellular uptake and impact of ferucarbotran on macrophage physiology
-
C. Y. Yang, M. F. Tai, C. P. Lin, C. W. Lu, J. L. Wang, J. K. Hsiao, and H. M. Liu, Mechanism of cellular uptake and impact of ferucarbotran on macrophage physiology. PLoS One 6, e25524 (2011).
-
(2011)
PLoS One
, vol.6
, pp. e25524
-
-
Yang, C.Y.1
Tai, M.F.2
Lin, C.P.3
Lu, C.W.4
Wang, J.L.5
Hsiao, J.K.6
Liu, H.M.7
-
38
-
-
84866490114
-
STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review)
-
X. Wang, P. J. Crowe, D. Goldstein, and J. L. Yang, STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review). Int. J. Oncol. 41, 1181 (2012).
-
(2012)
Int. J. Oncol.
, vol.41
, pp. 1181
-
-
Wang, X.1
Crowe, P.J.2
Goldstein, D.3
Yang, J.L.4
-
39
-
-
20444453281
-
A role of STAT3 in Rho GTPase-regulated cell migration and proliferation
-
M. Debidda, L. Wang, H. Zang, V. Poli, and Y. Zheng, A role of STAT3 in Rho GTPase-regulated cell migration and proliferation. J. Biol. Chem. 280, 17275 (2005).
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 17275
-
-
Debidda, M.1
Wang, L.2
Zang, H.3
Poli, V.4
Zheng, Y.5
-
40
-
-
79953698725
-
HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion
-
Y. Sekine, K. Suzuki, and A. T. Remaley, HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion. Prostate 71, 690 (2011).
-
(2011)
Prostate
, vol.71
, pp. 690
-
-
Sekine, Y.1
Suzuki, K.2
Remaley, A.T.3
-
41
-
-
0034900897
-
Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma
-
E. Sabo, A. Boltenko, Y. Sova, A. Stein, S. Kleinhaus, and M. B. Resnick, Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin. Cancer Res. 7, 533 (2001).
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 533
-
-
Sabo, E.1
Boltenko, A.2
Sova, Y.3
Stein, A.4
Kleinhaus, S.5
Resnick, M.B.6
-
42
-
-
70349395222
-
Antiandrogena and androgen depleting therapies in prostate cancer: Novel agents for an established target
-
Y. Chen, N. J. Clegg, and H. I. Scher, Antiandrogena and androgen depleting therapies in prostate cancer: Novel agents for an established target. Lancet Oncol. 10, 981 (2009).
-
(2009)
Lancet Oncol.
, vol.10
, pp. 981
-
-
Chen, Y.1
Clegg, N.J.2
Scher, H.I.3
-
43
-
-
41149159755
-
A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine geneengineered MSCs
-
X. C. Chen, X. J. Lin, J. L. Zhao, W. Shi, H. Zhang, Y. S. Wang, Y. Wei, Y. Liu, and X. Zhao, A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine geneengineered MSCs. Mol. Ther. 16, 749 (2008).
-
(2008)
Mol. Ther.
, vol.16
, pp. 749
-
-
Chen, X.C.1
Lin, X.J.2
Zhao, J.L.3
Shi, W.4
Zhang, H.5
Wang, Y.S.6
Wei, Y.7
Liu, Y.8
Zhao, X.9
-
44
-
-
84896968253
-
Prostate cancer targeting with 7E11-C5.3-CdS bioconjugated quantum dots
-
S. Rajaram, P. Bhujbal, I. J. Slipper, M. E. Favretto, and D. Douroumis, Prostate cancer targeting with 7E11-C5.3-CdS bioconjugated quantum dots. J. Colloid Sci. Biotechnol. 2, 34 (2013).
-
(2013)
J. Colloid Sci. Biotechnol.
, vol.2
, pp. 34
-
-
Rajaram, S.1
Bhujbal, P.2
Slipper, I.J.3
Favretto, M.E.4
Douroumis, D.5
-
45
-
-
0033866215
-
Cell adhesion and chemotaxis in prostate cancer metastasis to bone: A mini review
-
C. R. Cooper and K. J. Pienta, Cell adhesion and chemotaxis in prostate cancer metastasis to bone: A mini review. Prostate Cancer Prostatic Dis. 3, 6 (2000).
-
(2000)
Prostate Cancer Prostatic Dis.
, vol.3
, pp. 6
-
-
Cooper, C.R.1
Pienta, K.J.2
-
46
-
-
33644834768
-
Camptothecin and podophyllotoxin derivates: Inhibitors of topoisomerase I and II-mechanism of action, pharmacokinetics and toxicity profile
-
J. T. Hartmann and H. P. Lipp, Camptothecin and podophyllotoxin derivates: Inhibitors of topoisomerase I and II-mechanism of action, pharmacokinetics and toxicity profile. Drug Saf. 29, 209 (2003).
-
(2003)
Drug Saf.
, vol.29
, pp. 209
-
-
Hartmann, J.T.1
Lipp, H.P.2
-
48
-
-
77956227263
-
In vivo antitumor and antimetastatic activities of camptothecin encapsulated with N-trimethyl chitosan in a preclinical mouse model of liver cancer
-
L. Zhou, X. Li, X. Chen, Z. Li, X. Liu, S. Zhou, Q. Zhong, T. Yi, Y. Wei, X. Zhao, and Z. Qian, In vivo antitumor and antimetastatic activities of camptothecin encapsulated with N-trimethyl chitosan in a preclinical mouse model of liver cancer. Cancer Lett. 297, 56 (2010).
-
(2010)
Cancer Lett.
, vol.297
, pp. 56
-
-
Zhou, L.1
Li, X.2
Chen, X.3
Li, Z.4
Liu, X.5
Zhou, S.6
Zhong, Q.7
Yi, T.8
Wei, Y.9
Zhao, X.10
Qian, Z.11
-
49
-
-
57749092182
-
Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
-
J. Ma and D. J. Waxman, Combination of antiangiogenesis with chemotherapy for more effective cancer treatment. Mol. Cancer Ther. 7, 3670 (2008).
-
(2008)
Mol. Cancer Ther.
, vol.7
, pp. 3670
-
-
Ma, J.1
Waxman, D.J.2
-
50
-
-
77952517942
-
Mechanism of lymph node metastasis in prostate cancer
-
K. Datta, M. Muders, H. Zhang, and D. J. Tindall, Mechanism of lymph node metastasis in prostate cancer. Future Oncol. 6, 823 (2010).
-
(2010)
Future Oncol.
, vol.6
, pp. 823
-
-
Datta, K.1
Muders, M.2
Zhang, H.3
Tindall, D.J.4
-
51
-
-
33845650679
-
A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9
-
L. C. Sun, J. Luo, L. V. Mackey, J. A. Fuselier, and D. H. Coy, A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. Cancer Lett. 246, 157 (2007).
-
(2007)
Cancer Lett.
, vol.246
, pp. 157
-
-
Sun, L.C.1
Luo, J.2
Mackey, L.V.3
Fuselier, J.A.4
Coy, D.H.5
-
52
-
-
0036304427
-
Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins
-
R. Garcia-Carbonero and J. G. Supko, Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin. Cancer Res. 8, 641 (2002).
-
(2002)
Clin. Cancer Res.
, vol.8
, pp. 641
-
-
Garcia-Carbonero, R.1
Supko, J.G.2
-
53
-
-
84960107123
-
-
edited by Wiley, Baton Rouge, LA, USA
-
K. Challa, Nanomaterials for Cancer Therapy, edited by Wiley, Baton Rouge, LA, USA (2007), Vol. 6, pp. 1-39.
-
(2007)
Nanomaterials for Cancer Therapy
, vol.6
, pp. 1-39
-
-
Challa, K.1
-
54
-
-
67649448820
-
Reorganization of the integrin alpha2 subunit controls cell adhesion and cancer cell invasion in prostate cancer
-
S. V. Slambrouck, A. R. Jenkins, A. E. Romero, and W. F. Steelant, Reorganization of the integrin alpha2 subunit controls cell adhesion and cancer cell invasion in prostate cancer. Int. J. Oncol. 34, 1717 (2009).
-
(2009)
Int. J. Oncol.
, vol.34
, pp. 1717
-
-
Slambrouck, S.V.1
Jenkins, A.R.2
Romero, A.E.3
Steelant, W.F.4
-
55
-
-
0034658698
-
STATs in oncogenesis
-
T. Bowman, R. Garcia, J. Turkson, and R. Jove, STATs in oncogenesis. Oncogene 19, 2474 (2000).
-
(2000)
Oncogene
, vol.19
, pp. 2474
-
-
Bowman, T.1
Garcia, R.2
Turkson, J.3
Jove, R.4
-
56
-
-
77957137452
-
Janus-activated kinases and signal transducer and activator of transcription control tumor growth response to camptothecin in human colon cancer cells
-
H. J. Yun, S. Y. Kim, Y. Y. Kwon, C. H. Kim, C. M. Kang, and E. J. Kim, Janus-activated kinases and signal transducer and activator of transcription control tumor growth response to camptothecin in human colon cancer cells. Cancer Biol. Ther. 10, 354 (2010).
-
(2010)
Cancer Biol. Ther.
, vol.10
, pp. 354
-
-
Yun, H.J.1
Kim, S.Y.2
Kwon, Y.Y.3
Kim, C.H.4
Kang, C.M.5
Kim, E.J.6
-
57
-
-
77958126831
-
Microtubule-targeted chemotherapeutic agents inhibit signal transducer and activator of transcription 3 (STAT3) signaling
-
S. R. Walker, M. Chaudhury, E. A. Nelson, and D. A. Frank, Microtubule-targeted chemotherapeutic agents inhibit signal transducer and activator of transcription 3 (STAT3) signaling. Mol. Pharmacol. 78, 903 (2010).
-
(2010)
Mol. Pharmacol.
, vol.78
, pp. 903
-
-
Walker, S.R.1
Chaudhury, M.2
Nelson, E.A.3
Frank, D.A.4
-
58
-
-
84873307557
-
STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells
-
Z. Wei, X. Jiang, H. Qiao, B. Zhai, L. Zhang, Q. Zhang, Y. Wu, H. Jiang, and X. Sun, STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells. Cell Signal. 25, 931 (2013).
-
(2013)
Cell Signal.
, vol.25
, pp. 931
-
-
Wei, Z.1
Jiang, X.2
Qiao, H.3
Zhai, B.4
Zhang, L.5
Zhang, Q.6
Wu, Y.7
Jiang, H.8
Sun, X.9
-
59
-
-
24144475549
-
Clinical and pathologic significance of activation of signal transducer and activator of transcription 3 in prostate cancer
-
M. Horinaga, H. Okita, J. Nakashima, K. Kanao, M. Sakamoto, and M. Murai, Clinical and pathologic significance of activation of signal transducer and activator of transcription 3 in prostate cancer. Urology 66, 671 (2005).
-
(2005)
Urology
, vol.66
, pp. 671
-
-
Horinaga, M.1
Okita, H.2
Nakashima, J.3
Kanao, K.4
Sakamoto, M.5
Murai, M.6
-
60
-
-
0026083903
-
Tumor angiogenesis and metastasis correlation in invasive breast carcinoma
-
N. Weidner, J. P. Semple, W. R. Welch, and J. Folkman, Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1 (1991).
-
(1991)
N. Engl. J. Med.
, vol.324
, pp. 1
-
-
Weidner, N.1
Semple, J.P.2
Welch, W.R.3
Folkman, J.4
-
61
-
-
84865446375
-
-
Edited by E. Bilensoy, Wiley Online Library, Hoboken
-
F. Trotta, Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications, Edited by E. Bilensoy, Wiley Online Library, Hoboken (2011), Vol. 1, pp. 323-342.
-
(2011)
Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications
, vol.1
, pp. 323-342
-
-
Trotta, F.1
-
62
-
-
84888202520
-
Nanopreparations to overcome multidrug resistance in cancer
-
N. R. Patel, B. S. Pattni, A. H. Abouzeid, and V. P. Torchilin, Nanopreparations to overcome multidrug resistance in cancer. Adv. Drug Deliv. Rev. 65, 1748 (2013).
-
(2013)
Adv. Drug Deliv. Rev.
, vol.65
, pp. 1748
-
-
Patel, N.R.1
Pattni, B.S.2
Abouzeid, A.H.3
Torchilin, V.P.4
-
63
-
-
84926350446
-
Acute and repeated dose toxicity studies of different β-cyclodextrin-based nanosponge formulations
-
P. Shende, Y. A. Kulkarni, R. S. Gaud, K. Deshmukh, R. Cavalli, F. Trotta, and F. Caldera, Acute and repeated dose toxicity studies of different β-cyclodextrin-based nanosponge formulations. J. Pharm. Sci. (2015).
-
(2015)
J. Pharm. Sci.
-
-
Shende, P.1
Kulkarni, Y.A.2
Gaud, R.S.3
Deshmukh, K.4
Cavalli, R.5
Trotta, F.6
Caldera, F.7
|